The Food and Drug Administration (FDA) on Wednesday granted emergency authorization to Pfizer’s COVID-19 treatment pill, CNBC reported.
The medication, which is recommended for people at a high risk of developing severe COVID-19, could be available to patients as early as this weekend, according to the report. The Centers for Disease Control and Prevention is expected to quickly follow suit with its seal of approval, authorizing its distribution.
Read more